SECOND REGULAR SESSION
97TH GENERAL ASSEMBLY
INTRODUCED BY REPRESENTATIVES MORRIS (Sponsor), REMOLE, FRAKER, MESSENGER, FITZWATER, DIEHL, REHDER, LOVE, LANT, ALLEN, FREDERICK, ENGLISH, OTTO AND MIMS (Co-sponsors).
6391H.01I D. ADAM CRUMBLISS, Chief Clerk
AN ACT
To repeal sections 338.270 and 338.347, RSMo, and to enact in lieu thereof two new sections relating to nonresident pharmacy licenses.
Be it enacted by the General Assembly of the state of Missouri, as follows:
Section A. Sections 338.270 and 338.347, RSMo, are repealed and two new sections enacted in lieu thereof, to be known as sections 338.270 and 338.347, to read as follows:
338.270. 1. Application blanks for renewal permits shall be mailed to each permittee on or before the first day of the month in which the permit expires and, if application for renewal of permit is not made before the first day of the following month, the existing permit, or renewal thereof, shall lapse and become null and void upon the last day of that month.
2. The board shall not renew a nonresident pharmacy license if the renewal applicant does not hold a current pharmacy license or its equivalent in the state in which the nonresident pharmacy is located.
338.347. 1. Application blanks for renewal of license shall be mailed to each licensee on or before the first day of the month in which the license expires and, if application for renewal of license with required fee is not made before the first day of the following month, the existing license, or renewal thereof, shall lapse and become null and void upon the last day of that month.
2. The board shall not renew an out-of-state wholesale drug distributor, out-of-state pharmacy distributor, or drug distributor license or registration if the renewal applicant does not hold a current distributor license or its equivalent in the state or jurisdiction in which the distribution facility is located; or if the applicant is a drug distributor registrant, the entity is not authorized and in good standing to operate as a drug manufacturer with the Food and Drug Administration or within the state or jurisdiction where the facility is located.
•